Additional information
| Active substance | Chloroquine |
|---|---|
| Water Retention | Minimal to none |
| Hepatotoxicity | Rare, but possible in cases of long-term use |
| Lab Test | Blood concentrations can be monitored, though not commonly done |
| Also known as | Chloroquine phosphate, Aralen |
| Blood pressure | Usually does not affect blood pressure significantly |
| Trade name | Aralen, Chloroquine Phosphate |
| Storage conditions | Store at room temperature, away from moisture and light |
| Chemical name | 7-Chloro-4-[(4-diethylamino-1-methylbutyl)amino]quinoline |
| Formula | C18H26ClN3 |
| Substance class | Aminoquinoline |
| Main action | Antimalarial, antirheumatic |
| Half-life | Approximately 1 to 2 months |
| Dosage (medical) | Typically 500 mg weekly for malaria prophylaxis, and 250 mg daily for rheumatic diseases |
| Dosage (sports) | Not applicable |
| Effects | Prevention and treatment of malaria, and management of autoimmune disorders like rheumatoid arthritis and lupus |
| Side effects | Retinopathy, muscle weakness, seizure, hearing loss, nausea, vomiting |
| Use in sports | Not typically used in sports |
| Manufacturer | Ipca Laboratories Ltd. |
| Packing | 30 tabs |
Cialis Tadalafil 20 mg 30 Tabletten
Januvia 100mg Merckgroup
Champix 56 tabs Pfizer
Tavanic 500 mg Sanofi
Zimaks 400 Bilim
Clomid Aaster Health and Sports Solutions
Zyban Glaxosmithkline
HCG USA PEPTIDES
Seretide Disckus (Advair) 500 mcg Glaxosmithkline
Beginner Bulking Cycle Ultima Pharmaceuticals
Prograf 1mg Astellas Pharma 

Reviews
There are no reviews yet.